Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-Center, Randomized Study to Assess the Ability of the Silq ClearTract™ Urinary Catheter to Reduce Biofilm Formation When Compared to Two Types of Commercially Available Foley Catheters (Silver-Coated Latex and Silicone-coated Latex)

NCT04841226 is registered in ClinicalTrials.gov with Silq Technologies Corporation as lead sponsor.

NCT NCT04841226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04841226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-Center, Randomized Study to Assess the Ability of the Silq ClearTract™ Urinary Catheter to Reduce Biofilm Formation When Compared to Two Types of Commercially Available Foley Catheters (Silver-Coated Latex and Silicone-coated Latex)
Lead sponsor
Silq Technologies Corporation
Phase
Not applicable
Overall status
Completed
Start date
December 28, 2021
Completion date
August 15, 2024
Enrollment
158 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

biofilm formation, uti